Comprehensive Analysis of Single Institution, Patient-Specific IMPT QA Data across 18 Disease Sites
To evaluate patient-specific quality assurance (PSQA) measurements across 18 disease sites treated with intensity modulated proton therapy (IMPT) from January 2024 through August 2025.
Poster Program · Therapy Physics